Zhanjun Hou

2.4k total citations
80 papers, 1.9k citations indexed

About

Zhanjun Hou is a scholar working on Molecular Biology, Rheumatology and Infectious Diseases. According to data from OpenAlex, Zhanjun Hou has authored 80 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 52 papers in Rheumatology and 25 papers in Infectious Diseases. Recurrent topics in Zhanjun Hou's work include Folate and B Vitamins Research (52 papers), Biochemical and Molecular Research (35 papers) and HIV/AIDS drug development and treatment (25 papers). Zhanjun Hou is often cited by papers focused on Folate and B Vitamins Research (52 papers), Biochemical and Molecular Research (35 papers) and HIV/AIDS drug development and treatment (25 papers). Zhanjun Hou collaborates with scholars based in United States, China and Italy. Zhanjun Hou's co-authors include Larry H. Matherly, Aleem Gangjee, Yijun Deng, Sita Kugel Desmoulin, Christina Cherian, Mike R. Wilson, Bharati Mitra, Lisa Polin, Kathryn White and Juiwanna Kushner and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemistry.

In The Last Decade

Zhanjun Hou

74 papers receiving 1.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Zhanjun Hou 1.1k 917 325 261 194 80 1.9k
John Galivan 1.4k 1.3× 774 0.8× 169 0.5× 455 1.7× 174 0.9× 106 2.6k
Gary B. Henderson 841 0.7× 779 0.8× 119 0.4× 418 1.6× 91 0.5× 67 1.8k
J F Kolhouse 1.3k 1.2× 1.3k 1.4× 37 0.1× 185 0.7× 63 0.3× 43 2.4k
Amos Gaikwad 781 0.7× 160 0.2× 79 0.2× 277 1.1× 104 0.5× 49 1.6k
James E. Dunford 1.6k 1.5× 188 0.2× 180 0.6× 2.1k 7.9× 445 2.3× 54 3.6k
A. Leyva 1.1k 1.0× 81 0.1× 212 0.7× 647 2.5× 63 0.3× 74 1.8k
David G. Williams 748 0.7× 270 0.3× 46 0.1× 548 2.1× 150 0.8× 80 2.1k
Krishnendu Roy 762 0.7× 212 0.2× 26 0.1× 133 0.5× 56 0.3× 24 1.1k
J.R. Bertino 462 0.4× 175 0.2× 69 0.2× 221 0.8× 69 0.4× 28 925
Wieger Hemrika 1.0k 0.9× 168 0.2× 58 0.2× 78 0.3× 170 0.9× 38 2.0k

Countries citing papers authored by Zhanjun Hou

Since Specialization
Citations

This map shows the geographic impact of Zhanjun Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanjun Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanjun Hou more than expected).

Fields of papers citing papers by Zhanjun Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhanjun Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanjun Hou. The network helps show where Zhanjun Hou may publish in the future.

Co-authorship network of co-authors of Zhanjun Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Zhanjun Hou. A scholar is included among the top collaborators of Zhanjun Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhanjun Hou. Zhanjun Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Forrest, A.R.W., et al.. (2025). One-Carbon Metabolism Inhibition Depletes Purines and Results in Profound and Prolonged Ewing Sarcoma Growth Suppression. Cancer Research Communications. 5(8). 1298–1309.
2.
Bao, Xun, Jing Li, Seongho Kim, et al.. (2025). Pharmacodynamic determinants of mitochondrial one-carbon flux and serine hydroxymethyltransferase inhibition in human tumors. Drug Metabolism and Disposition. 53(8). 100120–100120.
3.
Wang, Na, Zhanjun Hou, Yinghui Wang, et al.. (2025). Design, synthesis, and biological evaluation of membrane-active cannabichromene derivatives as potent antibacterial agents. European Journal of Medicinal Chemistry. 296. 117888–117888. 1 indexed citations
4.
Wu, Lin, et al.. (2025). A simulation study of biogeochemical interactions in cyclic underground bio-methanation of carbon dioxide and hydrogen. Petroleum Exploration and Development. 52(4). 1102–1112. 1 indexed citations
5.
Gogoi, Radhika, Sandra Galoforo, Alexandra Fox, et al.. (2024). BRCA Status Dictates Wnt Responsiveness in Epithelial Ovarian Cancer. Cancer Research Communications. 4(8). 2075–2088.
6.
Wallace-Povirk, Adrianne, Xun Bao, Jennifer Wong-Roushar, et al.. (2024). Mitochondrial and Cytosolic One-Carbon Metabolism Is a Targetable Metabolic Vulnerability in Cisplatin-Resistant Ovarian Cancer. Molecular Cancer Therapeutics. 23(6). 809–822. 8 indexed citations
7.
Wong-Roushar, Jennifer, Adrianne Wallace-Povirk, Xun Bao, et al.. (2023). Multitargeted 6-Substituted Thieno[2,3-d]pyrimidines as Folate Receptor-Selective Anticancer Agents that Inhibit Cytosolic and Mitochondrial One-Carbon Metabolism. ACS Pharmacology & Translational Science. 6(5). 748–770. 6 indexed citations
11.
Hou, Zhanjun, Yang Si, Adrianne Wallace-Povirk, et al.. (2017). Dual Targeting of Epithelial Ovarian Cancer Via Folate Receptor α and the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3- d ]pyrimidine Antifolates. Molecular Cancer Therapeutics. 16(5). 819–830. 38 indexed citations
12.
Giovannetti, Elisa, Paolo Andrea Zucali, Yehuda G. Assaraf, et al.. (2017). Role of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools. Annals of Oncology. 28(11). 2725–2732. 37 indexed citations
13.
Cherian, Christina, Sita Kugel Desmoulin, Lei Wang, et al.. (2013). Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter. Cancer Chemotherapy and Pharmacology. 71(4). 999–1011. 20 indexed citations
14.
Desmoulin, Sita Kugel, Lei Wang, Lisa Polin, et al.. (2012). Functional Loss of the Reduced Folate Carrier Enhances the Antitumor Activities of Novel Antifolates with Selective Uptake by the Proton-Coupled Folate Transporter. Molecular Pharmacology. 82(4). 591–600. 27 indexed citations
15.
Desmoulin, Sita Kugel, Zhanjun Hou, Aleem Gangjee, & Larry H. Matherly. (2012). The human proton-coupled folate transporter. Cancer Biology & Therapy. 13(14). 1355–1373. 126 indexed citations
16.
18.
Hou, Zhanjun & Bharati Mitra. (2003). The Metal Specificity and Selectivity of ZntA from Escherichia coli Using the Acylphosphate Intermediate. Journal of Biological Chemistry. 278(31). 28455–28461. 40 indexed citations
19.
Hou, Zhanjun, et al.. (2001). Functional Analysis of Chimeric Proteins of the Wilson Cu(I)-ATPase (ATP7B) and ZntA, a Pb(II)/Zn(II)/Cd(II)-ATPase fromEscherichia coli. Journal of Biological Chemistry. 276(44). 40858–40863. 42 indexed citations
20.
Yu, Jialin, Liying Yan, Ning Su, et al.. (1999). Analysis of nucleotide sequence of wheat yellow mosaic virus genomic RNAs. Science in China Series C Life Sciences. 42(5). 554–560. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026